In the ever-evolving field of diabetes management, glucagon-like peptide-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent advanced https://junaidliwm897042.free-blogz.com/86405946/glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide